A novel combination therapy targets sonic hedgehog signaling by the dual inhibition of HMG-CoA reductase and HSP90 in rats with non-alcoholic steatohepatitis.
Mohammed OA, Youssef ME, Doghish AS, Hamad RS, Abdel-Reheim MA, Alghamdi M, Alamri MMS, Alfaifi J, Adam MIE, Alharthi MH, Alhalafi AH, Bahashwan E, Rezigalla AA, BinAfif DF, Abdel-Ghany S, Attia MA, Elmorsy EA, Al-Noshokaty TM, Fikry H, Saleh LA, Saber S.
Mohammed OA, et al. Among authors: alghamdi m.
Eur J Pharm Sci. 2024 May 5;198:106792. doi: 10.1016/j.ejps.2024.106792. Online ahead of print.
Eur J Pharm Sci. 2024.
PMID: 38714237